Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus
Ahalya Anita Suntharalingam Kvist,
Archana Sharma,
Christine Sommer,
Elisabeth Qvigstad,
Hanne Løvdal Gulseth,
Stina Therese Sollid,
Ingrid Nermoen,
Naveed Sattar,
Jason Gill,
Tone Møller Tannæs,
Kåre Inge Birkeland,
Sindre Lee-Ødegård
Affiliations
Ahalya Anita Suntharalingam Kvist
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Archana Sharma
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Christine Sommer
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0424 Oslo, Norway
Elisabeth Qvigstad
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Hanne Løvdal Gulseth
Norwegian Institute of Public Health, 0213 Oslo, Norway
Stina Therese Sollid
Department of Medicine, Drammen Hospital, Vestre Viken Health Trust, 3004 Drammen, Norway
Ingrid Nermoen
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Naveed Sattar
School of Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK
Jason Gill
School of Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK
Tone Møller Tannæs
EpiGen, Medical Division, Akershus University Hospital, 1478 Lørenskog, Norway
Kåre Inge Birkeland
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
Sindre Lee-Ødegård
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway
South Asians (SAs) have a higher risk of developing type 2 diabetes (T2D) than white Europeans, especially following gestational diabetes mellitus (GDM). Despite similar blood glucose levels post-GDM, SAs exhibit more insulin resistance (IR) than Nordics, though the underlying mechanisms are unclear. This study aimed to assess markers of adipose tissue (AT) IR and liver fat in SA and Nordic women post-GDM. A total of 179 SA and 108 Nordic women in Norway underwent oral glucose tolerance tests 1–3 years post-GDM. We measured metabolic markers and calculated the AT IR index and non-alcoholic fatty liver disease liver fat (NAFLD-LFS) scores. Results showed that normoglycaemic SAs had less non-esterified fatty acid (NEFA) suppression during the test, resembling prediabetes/T2D responses, and higher levels of plasma fetuin-A, CRP, and IL-6 but lower adiponectin, indicating AT inflammation. Furthermore, normoglycaemic SAs had higher NAFLD-LFS scores, lower insulin clearance, and higher peripheral insulin than Nordics, indicating increased AT IR, inflammation, and liver fat in SAs. Higher liver fat markers significantly contributed to the ethnic disparities in glucose metabolism, suggesting a key area for intervention to reduce T2D risk post-GDM in SAs.